[1]
2020. Pharmacoeconomic aspects of warfarin and new oral anticoagulants use as prevention of thromboembolic complications in patients with atrial fibrillation. Ukrainian Journal of Cardiology. 27, 4 (Oct. 2020), 45–53. DOI:https://doi.org/10.31928/1608-635X-2020.4.4553.